116 related articles for article (PubMed ID: 23176621)
1. Why do targeted agents not work in the adjuvant setting in colon cancer?
Oyan B
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1337-45. PubMed ID: 23176621
[TBL] [Abstract][Full Text] [Related]
2. Targeted agents for adjuvant therapy of colon cancer.
Saif MW
Clin Colorectal Cancer; 2006 May; 6(1):46-51. PubMed ID: 16796791
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Medinger M; Steinbild S; Mross K
Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
[TBL] [Abstract][Full Text] [Related]
4. Targeted agents and oxaliplatin-containing regimens for the treatment of colon cancer.
Bonetti A; Giuliani J; Muggia F
Anticancer Res; 2014 Jan; 34(1):423-34. PubMed ID: 24403498
[TBL] [Abstract][Full Text] [Related]
5. Overstated conclusions of a pooled analysis of bevacizumab in colon cancer.
Goffin JR; Talavera JR
J Clin Oncol; 2006 Jan; 24(3):528-9; author reply 529-30. PubMed ID: 16421433
[No Abstract] [Full Text] [Related]
6. Targeted agents for adjuvant therapy of colon cancer.
de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S42-5. PubMed ID: 17178286
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-fluorouracil adjuvant treatment of colon cancer.
Kelder W; Hospers GA; Plukker JT
Expert Rev Anticancer Ther; 2006 May; 6(5):785-94. PubMed ID: 16759168
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer.
Moosmann N; Heinemann V
Expert Rev Anticancer Ther; 2008 Mar; 8(3):319-29. PubMed ID: 18366281
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
10. CALGB/SWOG C80405: A phase III trial of FOLFIRI or FOLFOX with bevacizumab or cetuximab or both for untreated metastatic adenocarcinoma of the colon or rectum.
Clin Adv Hematol Oncol; 2006 Jun; 4(6):452-3. PubMed ID: 16981668
[No Abstract] [Full Text] [Related]
11. Adjuvant therapy of colon cancer: current status and future directions.
Chung KY; Saltz LB
Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.
Whyte S; Pandor A; Stevenson M; Rees A
Health Technol Assess; 2010 Oct; 14(Suppl. 2):47-53. PubMed ID: 21047491
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
[TBL] [Abstract][Full Text] [Related]
14. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
Benson AB
Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
[TBL] [Abstract][Full Text] [Related]
15. Stage II and stage III colon cancer: treatment advances and future directions.
Rousseau B; Chibaudel B; Bachet JB; Larsen AK; Tournigand C; Louvet C; André T; de Gramont A;
Cancer J; 2010; 16(3):202-9. PubMed ID: 20526097
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
Shih T; Lindley C
Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
[TBL] [Abstract][Full Text] [Related]
19. New agents, combinations, and opportunities in the treatment of advanced and early-stage colon cancer.
Natarajan N; Shuster TD
Surg Clin North Am; 2006 Aug; 86(4):1023-43. PubMed ID: 16905422
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant therapy of colon carcinoma].
Trarbach T; Kubicka S; Hacker U; Ridwelski K; Reinacher-Schick A
Onkologie; 2008; 31 Suppl 5():19-23. PubMed ID: 19033700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]